Postdoctoral Scholar in Cancer Metastasis and Nanomedicine
A postdoctoral research position is now available at Vanderbilt University in the area of cancer metastasis and drug delivery. The King Lab is focused on using native immune cells as carriers for anti-cancer therapeutics, to target disseminating tumor cells and prevent the lymphatic and bloodborne spread of cancer. Ph.D. applicants should be experienced in xenograft mouse models of cancer metastasis. Expertise in cancer immunotherapy and nanoparticle technology is welcome, but not required.
For more information on our research, see the following references:
Mitchell MJ, Wayne E, Rana K, Schaffer CB, King MR. TRAIL-coated leukocytes that kill cancer cells in the circulation. Proc. Natl. Acad. Sci. U S A. 2014 111:930-5.
Chandrasekaran S, Chan MF, Li J, King MR. Super natural killer cells that target metastases in the tumor draining lymph nodes. Biomaterials. 2016 77:66-76.
Wayne EC, Chandrasekaran S, Mitchell MJ, Chan MF, Lee RE, Schaffer CB, King MR. TRAIL-coated leukocytes that prevent the bloodborne metastasis of prostate cancer. J. Controlled Release. 2016 223:215-23.
To apply, send a CV, cover letter, and list of three references to Prof. Michael King at firstname.lastname@example.org. This work is funded by the National Institutes of Health.